New Assessment System in Measuring Symptom Distress in Cancer Patients
New Assessment System in Measuring Symptom Distress in Cancer Patients
Recruiting · NCT00505245 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| New Assessment System in Measuring Symptom Distress in Cancer Patients | cancer, neoplasm | Recruiting | Not stated | 2026-07-29 | NCT00505245 |
8 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bayer | 178 |
| Bristol-Myers Squibb | 422 |
| Eli Lilly and Company | 370 |
| Genentech, Inc. | 221 |
| M.D. Anderson Cancer Center | 1145 |
| Merck Sharp & Dohme LLC | 650 |
| National Cancer Institute (NCI) | 3015 |
| National Institutes of Health (NIH) | 667 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| M D Anderson Cancer Center | Houston | United States | 667 |